Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Minority Interest: NT$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4186 Taiwan Advance Bio-Pharmaceutical Inc ROCO:4186
57 GF Score
Price NT$7.65
GF Value NT$15.92
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Taiwan Advance Bio-Pharmaceutical Minority Interest?

Taiwan Advance Bio-Pharmaceutical ROCO:4186 -1.03% 57 Minority Interest is NT$0.00 Mil as of Jun. 2026. GuruFocus rates ROCO:4186 with a GF Score™ of 57/100 and a GF Value™ of NT$15.92 (Possible Value Trap). The stock has 5 warning signs investors should review.

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Taiwan Advance Bio-Pharmaceutical's minority interest for the quarter that ended in Jun. 2026 was NT$0.00 Mil.

Taiwan Advance Bio-Pharmaceutical Minority Interest Historical Data

* Premium members only.

The historical data trend for Taiwan Advance Bio-Pharmaceutical's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiwan Advance Bio-Pharmaceutical Minority Interest Chart

Taiwan Advance Bio-Pharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Taiwan Advance Bio-Pharmaceutical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:4186
57GF Score
Taiwan Advance Bio-Pharmaceutical Inc ROCO:4186
Minority Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiwan Advance Bio-Pharmaceutical Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Frequently Asked Questions Learn more about Minority Interest →
What does a Minority Interest of NT$0.00 Mil mean?
Taiwan Advance Bio-Pharmaceutical (ROCO:4186) has a Minority Interest of NT$0.00 Mil as of Jun. 2026. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Taiwan Advance Bio-Pharmaceutical.
Is Taiwan Advance Bio-Pharmaceutical's Minority Interest too high?
Taiwan Advance Bio-Pharmaceutical's current Minority Interest is NT$0.00 Mil. Overall, Taiwan Advance Bio-Pharmaceutical has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Taiwan Advance Bio-Pharmaceutical's Minority Interest compare to VRTX and REGN?
Taiwan Advance Bio-Pharmaceutical's Minority Interest of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Minority Interest for a Biotechnology company?
A good Minority Interest depends on the Biotechnology industry context. However, Minority Interest should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Minority Interest mean?
A high Minority Interest can signal that a stock is expensive relative to its fundamentals. Minority interest represents the carrying value of equity from non-controlling shareholders and company partners. View historical data on Taiwan Advance Bio-Pharmaceutical. Taiwan Advance Bio-Pharmaceutical's current Minority Interest is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiwan Advance Bio-Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, Taiwan Advance Bio-Pharmaceutical (ROCO:4186) is currently considered Possible Value Trap. The stock's GF Value™ is NT$15.92, compared to a current price of NT$7.65 — trading 51.9% below its estimated fair value. The current Minority Interest is NT$0.00 Mil. Taiwan Advance Bio-Pharmaceutical's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Minority Interest calculated?
Minority Interest is calculated from a company's financial statements. For Taiwan Advance Bio-Pharmaceutical (ROCO:4186), the current Minority Interest is NT$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiwan Advance Bio-Pharmaceutical (ROCO:4186) Overvalued in 2026?

Based on GuruFocus' analysis, Taiwan Advance Bio-Pharmaceutical stock appears to be undervalued. The current stock price of NT$7.65 is trading 51.9% below its estimated GF Value™ of NT$15.92. GuruFocus considers Taiwan Advance Bio-Pharmaceutical to be Possible Value Trap.

Key valuation signals for ROCO:4186:

  • Minority Interest: NT$0.00 Mil
  • GF Value™: NT$15.92 vs. price of NT$7.65 (51.9% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the ROCO:4186 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Taiwan Advance Bio-Pharmaceutical Business Description

Address No. 363, Section 2, Fuxing South Road, 5th Floor, Daan District, New Taipei City, TWN, 22180
Taiwan Advance Bio-Pharmaceutical Inc operates in the food safety industry. The company's products include a Food safety test kit, Animal test kit, Pesticide test kit, Mycotoxin test kit, Nuleic acid extraction kit.
57GF Score

Get the complete analysis for ROCO:4186

Minority Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$7.65
Price
NT$15.92
GF Value